-
1دورية أكاديمية
المؤلفون: Scheen, André, WALLEMACQ, Caroline, Lancellotti, Patrizio
المصدر: Revue Médicale de Liège, 78 (10), 593-600 (2023-10)
مصطلحات موضوعية: LKC0U3A8NJ (evolocumab), EC 3.4.21.- (PCSK9 protein, human), EC 3.4.21.- (Proprotein Convertase 9), Anticholesteremic Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cholesterol, LDL, PCSK9 Inhibitors, Humans, Proprotein Convertase 9, Anticholesteremic Agents/therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, Cholesterol, LDL/therapeutic use, Cardiovascular Diseases/chemically induced, Secondary Prevention, Treatment Outcome, Atherosclerosis/drug therapy/etiology/prevention & control, Atherosclerotic cardiovascular disease, Evolocumab, Familial hypercholesterolaemia, LDL cholesterol, Monoclonal antibody, PCSK9, Human health sciences, Cardiovascular & respiratory systems, Sciences de la santé humaine, Systèmes cardiovasculaire & respiratoire
العلاقة: urn:issn:0370-629X; urn:issn:2566-1566
الوصول الحر: https://orbi.uliege.be/handle/2268/318578Test
-
2
المؤلفون: Steg, Philippe Gabriel, Hagström, Emil, Zobouyan, Isabelle
المصدر: Circulation. 140(2):103-112
مصطلحات موضوعية: acute coronary syndrome, alirocumab, cholesterol, mortality, PCSK9 protein
وصف الملف: electronic
الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-398707Test
https://doi.org/10.1161/CIRCULATIONAHA.118.038840Test
https://uu.diva-portal.org/smash/get/diva2:1377658/FULLTEXT01.pdfTest -
3دورية أكاديمية
المصدر: Endocrinology and Metabolism, Vol 36, Iss 2, Pp 279-295 (2021)
مصطلحات موضوعية: alirocumab, evolocumab, hydroxymethylglutaryl-coa reductase inhibitors, hyperlipoproteinemia type ii, pcsk9 protein, human, rna, small interfering, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
وصف الملف: electronic resource
العلاقة: http://www.e-enm.org/upload/pdf/enm-2021-964.pdfTest; https://doaj.org/toc/2093-596XTest; https://doaj.org/toc/2093-5978Test
-
4دورية أكاديمية
المؤلفون: Kyung Hoon Cho, Young Joon Hong
المصدر: The Korean Journal of Internal Medicine, Vol 35, Iss 5, Pp 1045-1058 (2020)
مصطلحات موضوعية: pcsk9 protein, human, cardiovascular diseases, antibodies, monoclonal, cholesterol, ldl, Medicine
وصف الملف: electronic resource
العلاقة: http://www.kjim.org/upload/pdf/kjim-2020-140.pdfTest; https://doaj.org/toc/1226-3303Test; https://doaj.org/toc/2005-6648Test
-
5دورية أكاديمية
المؤلفون: Marston, Nicholas A., Gurmu, Yared, Melloni, Giorgio E. M., Bonaca, Marc, Gencer, Baris, Sever, Peter S., Pedersen, Terje R., Keech, Anthony C., Roselli, Carolina, Lubitz, Steven A., Ellinor, Patrick T., O'Donoghue, Michelle L., Giugliano, Robert P., Ruff, Christian T., Sabatine, Marc S.
المصدر: Marston , N A , Gurmu , Y , Melloni , G E M , Bonaca , M , Gencer , B , Sever , P S , Pedersen , T R , Keech , A C , Roselli , C , Lubitz , S A , Ellinor , P T , O'Donoghue , M L , Giugliano , R P , Ruff , C T & Sabatine , M S 2020 , ' The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism ' , Circulation , vol. 141 , no. 20 ....
مصطلحات موضوعية: cholesterol, LDL, evolocumab, numbers needed to treat, PCSK9 protein, human, venous thromboembolism, LIPOPROTEIN(A), PREVENTION, ATHEROSCLEROSIS, ROSUVASTATIN, METAANALYSIS, THERAPY, STATINS
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1161/CIRCULATIONAHA.120.046397Test
https://hdl.handle.net/11370/cf927577-91fe-4bb4-b112-86547f3af881Test
https://research.rug.nl/en/publications/cf927577-91fe-4bb4-b112-86547f3af881Test
https://pure.rug.nl/ws/files/150709085/CIRCULATIONAHA.120.046397.pdfTest -
6دورية أكاديمية
المؤلفون: Marston, Nicholas A, Gurmu, Yared, Melloni, Giorgio E M, Bonaca, Marc, Gencer, Baris, Sever, Peter S, Pedersen, Terje R, Keech, Anthony C, Roselli, Carolina, Lubitz, Steven A, Ellinor, Patrick T, O'Donoghue, Michelle L, Giugliano, Robert P, Ruff, Christian T, Sabatine, Marc S
المصدر: ISSN: 0009-7322 ; Circulation, vol. 141, no. 20 (2020) p. 1600-1607.
مصطلحات موضوعية: info:eu-repo/classification/ddc/616, PCSK9 protein, human, Cholesterol, LDL, Evolocumab, Numbers needed to treat, Venous thromboembolism, Aged, Antibodies, Monoclonal, Humanized / adverse effects, Humanized / therapeutic use, Anticholesteremic Agents / adverse effects, Anticholesteremic Agents / therapeutic use, Biomarkers / blood, LDL / blood, Clinical Trials as Topic, Dyslipidemias / blood, Dyslipidemias / diagnosis, Dyslipidemias / drug therapy, Dyslipidemias / epidemiology, Female, Humans, Incidence, Lipoprotein(a) / blood, Male, Middle Aged, PCSK9 Inhibitors, Pulmonary Embolism / diagnosis
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32223429; https://archive-ouverte.unige.ch/unige:163128Test; unige:163128
-
7دورية أكاديمية
المؤلفون: Sang-Hak Lee
المصدر: Endocrinology and Metabolism, Vol 32, Iss 1, Pp 36-40 (2017)
مصطلحات موضوعية: Hyperlipoproteinemia type II, Genetics, Coronary disease, Hydroxymethylglutaryl-CoA reductase inhibitors, PCSK9 protein, human, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
وصف الملف: electronic resource
العلاقة: https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-32-36.pdfTest; https://doaj.org/toc/2093-596XTest; https://doaj.org/toc/2093-5978Test
-
8دورية أكاديمية
المؤلفون: Szarek, Michael, Steg, Philippe Gabriel, Bhatt, Deepak L., Bittner, Vera A., Bregeault, Marie-France, Dalby, Anthony J., Zeiher, Andreas M.
مصطلحات موضوعية: alirocumab, acute coronary syndrome, cholesterol, mortality, PCSK9 protein
العلاقة: Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Circulation; https://hdl.handle.net/11454/63464Test; https://doi.org/10.1161/CIRCULATIONAHA.118.038840Test; 140; 103; 112
الإتاحة: https://doi.org/10.1161/CIRCULATIONAHA.118.038840Test
https://hdl.handle.net/11454/63464Test -
9
المؤلفون: Michael Szarek, J. Wouter Jukema, Qian H Li, Harvey D. White, Investigators, Rafael Diaz, Deepak L. Bhatt, Robert Pordy, Shaun G. Goodman, Garen Manvelian, Timothée Sourdille, Gregory G. Schwartz, Philippe Gabriel Steg, Yong-Un Kim, Vera Bittner
المصدر: Circulation
Circulation, 143(11), 1109-1122. LIPPINCOTT WILLIAMS & WILKINSمصطلحات موضوعية: Male, PCSK9 protein, human, medicine.medical_specialty, Acute coronary syndrome, Low density lipoprotein cholesterol, Antibodies, Monoclonal, Humanized, LDL, acute coronary syndrome, Risk Factors, lipoprotein(a), Original Research Articles, Physiology (medical), Internal medicine, medicine, PCSK9 protein, Humans, human, Prospective Studies, Clinical efficacy, Propensity Score, lipoproteins, LDL, Aged, Lipoprotein cholesterol, Alirocumab, biology, business.industry, PCSK9 Inhibitors, Cholesterol, LDL, Lipoprotein(a), Middle Aged, medicine.disease, lipoproteins, Propensity score matching, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, biology.protein, Female, Cardiology and Cardiovascular Medicine, business, hydroxymethylglutaryl-CoA reductase inhibitors, Very high risk
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fa80e828fa1ebae1157ae2e6a7d23edTest
https://doi.org/10.1161/circulationaha.120.049447Test -
10دورية أكاديمية
المؤلفون: Xu, Shengtao, Luo, Shanshan, Zhu, Zheying, Xu, Jinyi
مصطلحات موضوعية: PCSK9 protein, Inhibitor, Small-molecule, LDL-C, Hypercholesterolemia, Natural products, Patent
العلاقة: https://nottingham-repository.worktribe.com/output/1370853Test; European Journal of Medicinal Chemistry; Volume 162; Pagination 212-233; https://nottingham-repository.worktribe.com/file/1370853/1/Accepted%20-%20EJMCTest-PCSK9-Nov%202018
الإتاحة: https://doi.org/10.1016/j.ejmech.2018.11.011Test
https://nottingham-repository.worktribe.com/file/1370853/1/Accepted%20-%20EJMCTest-PCSK9-Nov%202018
https://nottingham-repository.worktribe.com/output/1370853Test